To clarify the role of CD44 gene polymorphisms in oral cancer clinicopathologic statuses, such as tumor node metastasis clinical stage, tumor size, lymph node metastasis, distant metastasis, and cell differentiation, the distribution frequency of clinical statuses and CD44 genotype frequencies in oral cancer patients were estimated. This evidence concerns the gene CD44 and neoplasm.